View Document Preview and Link Document Date: 2004-06-21 07:58:21 Open Document File Size: 44,05 KB Share Result on Facebook
City Bristol / Greenville / / Company Catalytica Pharmaceuticals Inc. / Monarch Pharmaceuticals / TN 37620 / / IndustryTerm ophthalmic solution / sterile ophthalmic solution / treatment of herpes / chemical intolerance / chemical name / excess solution / aqueous solution / in vitro test systems / / MedicalCondition corneal ulcer / epithelial keratitis / herpes simplex virus keratoconjunctivitis / keratitis / stromal keratitis / uveal inflammation / adenocarcinomas / hemangiosarcomas / chronic toxicity study / ophthalmic infections / hyperemia / Carcinogenesis / carcinosarcomas / chlamydial infections / recurrent epithelial keratitis / granulosa-thecal cell tumors / primary keratoconjunctivitis / fetal death / hypersensitivity / irritation / mild local irritation / herpes simplex virus / herpetic keratitis / herpes simplex virus keratitis / neoplastic disease produce reversible bone marrow depression / uveitis / / Organization Continuous administration / DOSAGE AND ADMINISTRATION / / Position General / / Product VIROPTIC / sodium chloride / acetic acid / trifluridine / sodium acetate / / ProvinceOrState North Carolina / / Technology DNA synthesis / / SocialTag 
PRODUCT INFORMATION VIROPTIC� Ophthalmic Solution, 1% Sterile (trifluridine ophthalmic solution)